Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 May;72(5):3520-3.
doi: 10.1128/JVI.72.5.3520-3523.1998.

Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in seroconvertors infected with zidovudine-resistant variants

Affiliations

Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in seroconvertors infected with zidovudine-resistant variants

S Yerly et al. J Virol. 1998 May.

Abstract

Sequences of the human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) domain were determined by direct sequencing of HIV-1 RNA in successive plasma samples from eight seroconverting patients infected with virus bearing the T215Y/F amino acid substitution associated with zidovudine (ZDV) resistance. At baseline, additional mutations associated with ZDV resistance were detected. Three patients had the M41L amino acid change, which persisted. Two patients had both the D67N and the K70R amino acid substitutions; reversion to the wild type was seen at both positions in one of these patients and at codon 70 in the other one. Reversion to the wild type at codon 215 was observed in only one of eight patients. Unusual amino acids, such as aspartic acid (D) and cysteine (C), appeared at position 215 in four patients during follow-up. These variants isolated by coculturing were sensitive to ZDV. Overgrowth of these variants suggests that they have better fitness than the original T215Y variant. Intraindividual nucleoside substitutions over time were 10 times more frequent in codons associated with ZDV resistance (41, 67, 70, 215, and 219) than in other codons of the RT domain. The predominance of nonsynonymous substitutions observed over time suggests that most changes reflect adaptation of the RT function. The variance in sequence evolution observed among patients, in particular at codon 215, supports a role for chance in the evolution of the RT domain.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Amino acid substitutions in the RT domain for the five codons associated with ZDV resistance. Bold lines indicate the period of antiretroviral treatment. All treated patients were on ZDV monotherapy treatment, except for patient C, who was on ZDV plus didanosine treatment. WT, wild type; m, months.

Similar articles

Cited by

References

    1. Albert J, Wahlberg J, Lundeberg J, Cox S, Sadstrom E, Wahren B, Uhlen M. Persistence of azidothymidine-resistant human immunodeficiency virus type 1 RNA genotypes in posttreatment sera. J Virol. 1992;66:5627–5630. - PMC - PubMed
    1. Boucher C A, O’Sullivan E, Mulder J W, Ramautarsing C, Kellam P, Darby G, Lange J M, Goudsmit J, Larder B A. Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects. J Infect Dis. 1992;165:105–110. - PubMed
    1. Boucher C A, van Leeuven R, Kellam P, Schipper P, Tijnagel J, Lange J M, Larder B A. Effects of discontinuation of zidovudine treatment on zidovudine sensitivity of human immunodeficiency virus type 1 isolates. Antimicrob Agents Chemother. 1993;37:1525–1530. - PMC - PubMed
    1. Brun-Vezinet F, Ingrand D, Desforges L, Gochi K, Ferchal F, Schmitt M P, Jung M, Masquelier B, Aubert J, Buffet-Janvresse C, Fleury H. HIV-1 sensitivity to zidovudine: a consensus culture technique validated by genotypic analysis of the reverse transcriptase. J Virol Methods. 1992;37:177–188. - PubMed
    1. Coffin J M. HIV population dynamics in vivo: implication for genetic variation, pathogenesis, and therapy. Science. 1995;267:483–489. - PubMed

Publication types

MeSH terms